BRLT
Brilliant Earth Group, Inc.
BRLT has a slight edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BRLT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
BRLT's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BRLT PE Valuation
BRLT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 16x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BRLT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BRLT to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BRLT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | — |
| Q3 2026 | -$0.27 | -$0.24 |
| Q2 2026 | -$0.30 | -$0.27 |
| Q1 2026 | -$0.32 | -$0.31 |
| Q4 2025 | -$0.25 | -933% |
| Q3 2025 | -$0.03 | -250% |
| Q2 2025 | -$0.03 | -160% |
| Q1 2025 | -$0.01 | -120% |
BRLT lost $0.27 per share over the past year, a bigger loss than the year before.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over BRLT on earnings, with more consistent year-over-year improvement.
BRLT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.8M | +2.3% |
| Q2 2026 | $115.1M | +5.7% |
| Q1 2026 | $99.5M | +6% |
| Q4 2025 | $124.4M | +4.1% |
| Q3 2025 | $110.3M | +10% |
| Q2 2025 | $108.9M | +3.3% |
| Q1 2025 | $93.9M | -3.5% |
| Q4 2024 | $119.5M | -3.9% |
BRLT's revenue has grown year over year for six quarters in a row: $113M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.7% | +2.3 points |
| Q2 2026 | 0.4% | +1.5 points |
| Q1 2026 | -8.9% | -5.2 points |
| Q4 2025 | 0% | -2 points |
| Q3 2025 | -0.6% | +0.5 points |
| Q2 2025 | -1.1% | -2.2 points |
| Q1 2025 | -3.8% | -4.7 points |
| Q4 2024 | 2% | +1.1 points |
BRLT has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BRLT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BRLT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | +$3.9M |
| Q2 2026 | $16.5M | +109% |
| Q1 2026 | -$19.3M | -$11.5M |
| Q4 2025 | $5.7M | -52% |
| Q3 2025 | -$3K | -100% |
| Q2 2025 | $7.9M | +23% |
| Q1 2025 | -$7.9M | -$1.5M |
| Q4 2024 | $11.9M | +26% |
BRLT has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BRLT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -107.9x | Net Cash |
| Q3 2025 | -23.7x | Net Cash |
| Q2 2025 | -40.6x | Net Cash |
| Q1 2025 | -20.4x | Net Cash |
| Q4 2024 | -12.3x | Net Cash |
| Q3 2024 | -13.2x | Net Cash |
| Q2 2024 | -9.4x | Net Cash |
| Q1 2024 | -9.0x | Net Cash |
BRLT has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BRLT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 61.6 | Neutral |
BRLT's weekly RSI is 44 (neutral) and its Stochastic is 62 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BRLT PE vs Consumer Cyclical Sector
| Metric | BRLT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BRLT has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BRLT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.45 | 12% below |
| 20 week MA | $1.34 | 5.2% below |
| 50 week MA | $1.41 | 9.9% below |
| 100 week MA | $1.61 | 21% below |
| 200 week MA | $2.33 | 45% below |
BRLT is in a downtrend: it's below all five of its weekly moving averages, and 45% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BRLT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.2 | $16.1 | +5.5% |
| 2022 | $16.1 | $4.09 | -75% |
| 2023 | $4.09 | $3.72 | -9% |
| 2024 | $3.72 | $2.04 | -45% |
| 2025 | $2.04 | $1.78 | -13% |
| 2026 YTD | $1.78 | $1.27 | -29% |
BRLT has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.